Compound information
- Natural Products
- ZC1399739
- Molecular Formula
- C22H26N2O4
- Molecular Weight
- 382.189257312 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-1-[[(1R)-1-benzyl-2-oxo-ethyl]carbamoyl]-2-methyl-propyl]carbamate
- InChI
- InChI=1S/C22H26N2O4/c1-16(2)20(24-22(27)28-15-18-11-7-4-8-12-18)21(26)23-19(14-25)13-17-9-5-3-6-10-17/h3-12,14,16,19-20H,13,15H2,1-2H3,(H,23,26)(H,24,27)/t19-,20+/m1/s1
- InChI Key
- NGBKFLTYGSREKK-UXHICEINSA-N
- SMILES
- CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](C=O)Cc1ccccc1
- Source
- ZINC000001534489
Warheads
- Carbamate
-
- Aldehydic carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 28 | Ring Count | 2 |
Heteroatom Count | 6 | Rotatable Bond Count | 9 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 84.5 Å2 | LogP | 3.091 |
LogS | -4.008 | LogD | 3.374 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.757 | Pgp substrate | 0.012 |
HIA | 0.96 | F20 % | 0.991 |
F30 % | 0.955 | Caco-2 | -4.46 |
MDCK | -4.603 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.577 | PPB | 94.529 |
VD | 0.423 | Fu | 1.385 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.025 | CYP1A2 substrate | 0.795 |
CYP2A6 substrate | 0.6 | CYP2B6 substrate | 0.664 |
CYP2C19 inhibitor | 0.306 | CYP2C19 substrate | 0.947 |
CYP2C8 substrate | 0.9 | CYP2C9 inhibitor | 0.405 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.049 |
CYP2D6 substrate | 0.822 | CYP2E1 substrate | 0.377 |
CYP3A4 inhibitor | 0.511 | CYP3A4 substrate | 0.998 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.8 | CL | 6.311 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.006 | Hepatotoxicity | 0.993 |
Mutagenicity | 0.374 | Rat Oral Acute Toxicity | 0.173 |
FDAMDD | 0.429 | Skin Sensitization | 0.721 |
Carcinogenicity | 0.008 | Eye Corrosion | 0.01 |
Eye Irritation | 0.024 | Respiratory Toxicity | 0.023 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.085 | IGC50 | 3.862 |
LC50FM | 4.075 | LC50DM | 5.404 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.146 | NR-AR-LBD | 0.243 |
NR-AhR | 0.003 | NR-Aromatase | 0.054 |
NR-ER | 0.365 | NR-ER-LBD | 0.344 |
NR-PPAR-gamma | 0.268 | SR-ARE | 0.263 |
SR-ATAD5 | 0.261 | SR-HSE | 0.112 |
SR-MMP | 0.144 | SR-p53 | 0.023 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.